Jacobs Levy Equity Management’s Outset Medical OM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-3,683
Closed -$37.4K 1018
2024
Q3
$37.4K Sell
3,683
-22,731
-86% -$676K ﹤0.01% 941
2024
Q2
$1.53M Sell
26,414
-120
-0.5% -$5.88K 0.01% 653
2024
Q1
$884K Buy
26,534
+6,084
+30% +$308K ﹤0.01% 737
2023
Q4
$1.66M Buy
+20,450
New +$1.66M 0.01% 638

Other funds holding OM

Jacobs Levy Equity Management's OM Position: Q4 2024 in Review

Jacobs Levy Equity Management sold out of Outset Medical (OM) in Q4 2024, closing a stake of 3,683 shares — an estimated $37.4K sold.

Jacobs Levy Equity Management first reported a position in OM in Q4 2023 and held it in 4 quarters. The position peaked at $1.66M in Q4 2023. 73 funds tracked by Wall St. Rank hold OM as of Q4 2024.

  • Jacobs Levy Equity Management reported no remaining Outset Medical position as of Q4 2024 after selling out during the quarter.
  • Jacobs Levy Equity Management sold 3,683 Outset Medical shares in Q4 2024, an estimated $37.4K.
  • Jacobs Levy Equity Management first reported a position in Outset Medical in Q4 2023 and held it in 4 quarters.
  • Jacobs Levy Equity Management's Outset Medical position peaked at $1.66M in Q4 2023.
  • 73 funds tracked by Wall St. Rank held Outset Medical as of Q4 2024.

Based on Jacobs Levy Equity Management's 13F filing for Q4 2024, filed 14 Feb 2025.